Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer

Lung Cancer

Volumn 35, Issue 1, 2002, Pages 23-28

  Villegas, Francisco R ^a   Coca, Santiago ^a   Villarrubia, Vicente G ^b   Jiménez, Rodrigo ^a   Chillón, María Jesús ^a   Jareño, Javier ^a   Zuil, Marcos ^a   Callol, Luis ^a  

^a Hospital del Aire   (Spain)

^b Division de Inmunologia   (Spain)

Author keywords

Immunohistochemistry; Natural killer cells; Prognostic significance; Squamous cell lung carcinoma

Indexed keywords

CD57 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENDOSCOPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANTIGENS, CD57; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM STAGING; PROGNOSIS; SMOKING;

EID: 0036136050     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00292-6     Document Type: Article

References (44)

1. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
2. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo
3. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases
4. Natural killer cells and tumor therapy
5. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix
6. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma
7. Prognostic value of intratumoral natural killer cells in gastric carcinoma
8. Prognostic significance of natural killer cell activity in patients with laryngeal carcinoma
9. Natural killer cell activity in patients with hepatocellular carcinoma: A new prognostic indicator after hepatectomy
10. Interleukin-12: A cytokine at the interface of inflammation and immunity
11. Human papillomavirus infection in women infected with the human immunodeficiency virus
12. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allografts recipients
13. Human papillomaviruses
14. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma
15. Physical state and expression of human papilloma virus in laryngeal carcinoma and surrounding normal mucosa
16. Human papillomavirus-11 DNA in a patient with chronic laryngotracheal papillomatosis and metastatic squamous cell carcinoma of the lung
17. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication
18. Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas
19. Squamous carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis
20. A survey of human cancers for human papillomavirus DNA by filter hybridization
21. The predictive value of human papillomavirus (HPV) typing in the prognosis of bronchial squamous cell papillomas
22. Human papillomavirus type 16 related DNA in an anaplastic carcinoma of the lung
23. Human papillomavirus DNA in bronchial squamous cell carcinomas
24. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction
25. Effect of smoking on human natural killer cell activity
26. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity. Reversal by immunomodulation with oral AM3
27. Effect of smoking on natural killer cell activity in the lung
28. Inhibition of natural killer cell activity in mice treated with tobacco specific carcinogen NNK
29. Partial regression in primary carcinoma of the lung: Does it occur?
30. Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer
31. Revisions in the international system for staging lung cancer
32. Monoclonal antibody (anti-Leu-7) directed against natural killer cells reacts with normal, benign, and malignant prostate tissues
33. Immune cell infiltrates and prognosis in primary carcinoma of the lung
34. Augmentation of tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes
35. Generation and characterization of killer cells
36. Recall response to cytomegalovirus in allograft recipients: Mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartement
37. Liver NK1.1+CD4+αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
38. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
39. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
40. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
41. Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication
42. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways
43. The immunological basis of vaccine development
44. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells